Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]. (Q37571402)

21 August 2017

1 reference

title

Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]. (English)

1 reference

neurofibromatosis type II

21 August 2017

main subject

1 reference

1

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

11

1 reference

21 August 2017

issue

9

1 reference

21 August 2017

page(s)

599-610

1 reference

https://scigraph.springernature.com/pub.10.1097/gim.0b013e3181ac9a27

21 August 2017

exact match

0 references

cites work

Paediatric presentation of type 2 neurofibromatosis

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Evaluation of clinical diagnostic criteria for neurofibromatosis 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Use of MRI and audiological tests in presymptomatic diagnosis of type 2 neurofibromatosis (NF2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Management of the patient and family with neurofibromatosis 2: a consensus conference statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Constitutional de novo interstitial deletion of 8 Mb on chromosome 22q12.1-12.3 encompassing the neurofibromatosis type 2 (NF2) locus in a dysmorphic girl with severe malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Constitutional rearrangements of chromosome 22 as a cause of neurofibromatosis 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Mutation scanning of the NF2 gene: an improved service based on meta-PCR/sequencing, dosage analysis, and loss of heterozygosity analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

The distribution of constitutional and somatic mutations in the neurofibromatosis 2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

What are the implications in individuals with unilateral vestibular schwannoma and other neurogenic tumors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

The neuroimaging and clinical spectrum of neurofibromatosis 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Predictors of the risk of mortality in neurofibromatosis 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Spinal tumors in neurofibromatosis type 2. Is emerging knowledge of genotype predictive of natural history?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

NF2 status of meningiomas is associated with tumour localization and histology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Multiple meningiomas: differential involvement of the NF2 gene in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Ocular abnormalities in neurofibromatosis 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Probability of bilateral disease in people presenting with a unilateral vestibular schwannoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

NF2 tumor suppressor gene: a comprehensive and efficient detection of somatic mutations by denaturing HPLC and microarray-CGH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Germline mutation of INI1/SMARCB1 in familial schwannomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Diagnostic criteria for schwannomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

A case of multiple cutaneous schwannomas; schwannomatosis or neurofibromatosis type 2?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Familial meningioma: analysis of expression of neurofibromatosis 2 protein Merlin. Report of two cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Hearing changes after diagnosis in neurofibromatosis type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Vestibular schwannoma growth rates in neurofibromatosis type 2 natural history consortium subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Neurofibromatosis 2, radiosurgery and malignant nervous system tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

A parturient with neurofibromatosis type 2: anesthetic and obstetric considerations for delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Epidural anesthesia in a parturient with neurofibromatosis type 2 undergoing cesarean section.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Neurofibromatosis 2 leads to higher incidence of strabismological and neuro-ophthalmological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Magic but treatable? Tumours due to loss of merlin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181AC9A27

10.1097/GIM.0B013E3181AC9A27

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

21 August 2017

1030226277

0 references

1 reference